Get a better grip on mRNA therapeutics
Solutions to support your mRNA-LNP journey from research to manufacturing
Because mRNA offers a range of clinical and manufacturing advantages, it has the potential to revolutionize disease treatment and prevention. But mRNA-LNP therapies are precise and targeted, making it hard to avoid process and regulatory pitfalls. Cytiva can help implement solutions and strategy that advance your mRNA therapeutics.
Discover how Cytiva’s end-to-end solutions and technical know-how can support mRNA-LNP formulation.
Keep control of your IVT process with the WAVE™ 25 bioreactor system
Download this poster and discover how to build reproducibility into mRNA IVT processes from the start of your manufacturing journey.
T-series TFF cassettes with Delta 100 kDa membranes for RNA and LNP applications
Read application note to learn more about the performance of Cytiva’s TFF cassettes with 100 kDA molecular weight cutoff membranes for effective tangential flow filtration of RNA and LNPs
Digital solutions advance your mRNA manufacturing workflow
Read paper and learn how paperless manufacturing reduces documentation burden of the mRNA manufacturing workflow.
At Cytiva, our mission is to advance and accelerate the development of therapeutics. With nearly 16 000 associates in more than 40 countries, we’re driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma, and contract manufacturers. Learn more at cytiva.com.
